» Articles » PMID: 28236968

Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor

Overview
Publisher Elsevier
Date 2017 Feb 27
PMID 28236968
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages are found in all tissues and regulate tissue morphogenesis during development through trophic and scavenger functions. The colony stimulating factor-1 (CSF-1) receptor (CSF-1R) is the major regulator of tissue macrophage development and maintenance. In combination with receptor activator of nuclear factor κB (RANK), the CSF-1R also regulates the differentiation of the bone-resorbing osteoclast and controls bone remodeling during embryonic and early postnatal development. CSF-1R-regulated macrophages play trophic and remodeling roles in development. Outside the mononuclear phagocytic system, the CSF-1R directly regulates neuronal survival and differentiation, the development of intestinal Paneth cells and of preimplantation embryos, as well as trophoblast innate immune function. Consistent with the pleiotropic roles of the receptor during development, CSF-1R deficiency in most mouse strains causes embryonic or perinatal death and the surviving mice exhibit multiple developmental and functional deficits. The CSF-1R is activated by two dimeric glycoprotein ligands, CSF-1, and interleukin-34 (IL-34). Homozygous Csf1-null mutations phenocopy most of the deficits of Csf1r-null mice. In contrast, Il34-null mice have no gross phenotype, except for decreased numbers of Langerhans cells and microglia, indicating that CSF-1 plays the major developmental role. Homozygous inactivating mutations of the Csf1r or its ligands have not been reported in man. However, heterozygous inactivating mutations in the Csf1r lead to a dominantly inherited adult-onset progressive dementia, highlighting the importance of CSF-1R signaling in the brain.

Citing Articles

Wild-type bone marrow cells repopulate tissue resident macrophages and reverse the impacts of homozygous CSF1R mutation.

Carter-Cusack D, Huang S, Keshvari S, Patkar O, Sehgal A, Allavena R PLoS Genet. 2025; 21(1):e1011525.

PMID: 39869647 PMC: 11785368. DOI: 10.1371/journal.pgen.1011525.


Typical development of synaptic and neuronal properties can proceed without microglia in the cortex and thalamus.

OKeeffe M, Booker S, Walsh D, Li M, Henley C, Simoes de Oliveira L Nat Neurosci. 2025; 28(2):268-279.

PMID: 39762658 PMC: 11802452. DOI: 10.1038/s41593-024-01833-x.


Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury.

Ahmad S, Nasser W, Ahmad A Front Immunol. 2024; 15:1488913.

PMID: 39582870 PMC: 11581858. DOI: 10.3389/fimmu.2024.1488913.


Switch to phagocytic microglia by CSFR1 inhibition drives amyloid-beta clearance from glutamatergic terminals rescuing LTP in acute hippocampal slices.

Piccioni G, Maisto N, dEttorre A, Strimpakos G, Nistico R, Triaca V Transl Psychiatry. 2024; 14(1):338.

PMID: 39179543 PMC: 11344079. DOI: 10.1038/s41398-024-03019-2.


Identification and characterization of a novel intronic splicing mutation in CSF1R-related leukoencephalopathy.

Han Y, Han J, Li Z, Chen S, Liu J, Zhou R CNS Neurosci Ther. 2024; 30(6):e14815.

PMID: 38922778 PMC: 11194178. DOI: 10.1111/cns.14815.


References
1.
Itokowa T, Zhu M, Troiano N, Bian J, Kawano T, Insogna K . Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity. Calcif Tissue Int. 2010; 88(1):75-86. PMC: 3155765. DOI: 10.1007/s00223-010-9435-3. View

2.
Weilbaecher K, Motyckova G, Huber W, Takemoto C, Hemesath T, Xu Y . Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell. 2001; 8(4):749-58. DOI: 10.1016/s1097-2765(01)00360-4. View

3.
Mocsai A, Humphrey M, Van Ziffle J, Hu Y, Burghardt A, Spusta S . The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004; 101(16):6158-63. PMC: 395939. DOI: 10.1073/pnas.0401602101. View

4.
Abboud S, Woodruff K, Liu C, Shen V, Ghosh-Choudhury N . Rescue of the osteopetrotic defect in op/op mice by osteoblast-specific targeting of soluble colony-stimulating factor-1. Endocrinology. 2002; 143(5):1942-9. DOI: 10.1210/endo.143.5.8775. View

5.
Chitu V, Nacu V, Charles J, Henne W, McMahon H, Nandi S . PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood. 2012; 120(15):3126-35. PMC: 3471520. DOI: 10.1182/blood-2012-04-425595. View